← Eichor
Study identifier: NCT06069479 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Comparing Conservative to Surgical Treatment of Trigonocephaly Craniofacial Surgery in Children With Trigonocephaly: an Observational Cohort Study on Clinical Outcomes, Psychosocial Wellbeing, and Costs

Condition: Metopic Synostosis  ·  Sponsor: Erasmus Medical Center

PhaseN/A
Planned participants440
Who can joinAll sexes, N/A to 8 Years
Healthy volunteersNo

About this study

RESEARCH QUESTION Is the effectiveness of conservative policy comparable to that of surgery in children with trigonocephaly, with regard to clinical outcomes and psychosocial functioning, stress for parents, and costs? DESIGN Observational cohort study in children, aged 0 to 8 years old, with trigonocephaly, excluding metopic ridging (physiologic early closure of metopic suture), treated conservatively or surgically. OUTCOME MEASURES Primary: Head growth decline, indicating raised intracranial pressure Secondary: fundoscopy, cognition, behavior, refraction and vision, forehead shape, quality of life, posttraumatic stress, decisional conflict, costs.

This description comes directly from the study's public registry record.

Talk to the study team

Irene MJ Mathijssen, MD, PhD, MBA-H  ·  +31655758441  ·  i.mathijssen@erasmusmc.nl

Always discuss trial participation with your own doctor first.

Locations (1)

Erasmus MCRotterdam, ROTTERDAM, NetherlandsRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06069479